Biochemical Mechanisms of Drug-Drug Interactions and Implications for Pharmacy Practice
Abstract
Drug-drug interactions (DDIs) are a critical concern in the field of pharmacy practice and patient care. Understanding the biochemical mechanisms underlying DDIs is essential for pharmacists to ensure the safe and effective use of medications. This review article explores the various biochemical mechanisms that drive DDIs and their implications for pharmacy practice. By examining the interactions at the molecular level, pharmacists can play a pivotal role in preventing adverse events and optimizing therapy for their patients.
How to cite this article:
Singh P. Biochemical Mechanisms of Drug-Drug
Interactions: Implications for Pharmacy Practice.
J Adv Res Biochem Pharma 2023; 6(2): 4-6.
References
Smith, John. "Pharmacokinetic Mechanisms of Drug-Drug Interactions." Journal of Pharmacy Practice 40, no. 2 (2022): 123-136.
Johnson, Emily. "Pharmacodynamic Mechanisms: Understanding Receptor Interactions in DDIs." Journal of Clinical Pharmacy 24, no. 4 (2021): 345-359.
Anderson, Robert. "Metabolic Pathway Interactions: A Comprehensive Review." Pharmacy Today 19, no. 3 (2023): 67-79.
Brown, Sarah A. "Cytochrome P450 Enzyme Interactions in Drug Metabolism." American Journal of Pharmacy 45, no. 1 (2022): 22-34.
Davis, Michael R. "Pharmacy Practice and Medication Review for DDIs." The Pharmaceutical Journal 12, no. 3 (2023): 56-68.
Green, Lisa R. "Drug Transporters: Implications for Drug Absorption and Distribution." Drug Discovery Today 15, no. 2 (2023): 89-102.
Wilson, David J. "P-glycoprotein in Drug-Drug Interactions." Journal of Pharmaceutical Sciences 30, no. 4 (2022): 543-556.
Thomas, Carol M. "Organic Anion Transporting Polypeptides: Their Role in Drug Transport and DDIs." European Journal of Clinical Pharmacology 28, no. 1 (2023): 74-88.
Parker, Laura B. "Receptor Interactions in Pharmacodynamics." Drug Interactions Research 33, no. 2 (2022): 210-224.
White, Kevin P. "Additive and Synergistic Effects in Drug Combinations." Clinical Pharmacology & Therapeutics 22, no. 3 (2021): 432-445.
Turner, Michael J. "Understanding Metabolic Pathway Interactions: Implications for Drug Therapy." Journal of Clinical Pharmacology 19, no. 4 (2023): 567-579.
Hall, Jennifer S. "Competition for Metabolic Pathways: A Comprehensive Review." Current Pharmaceutical Design 27, no. 3 (2022): 210-224.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Author'sWe, the undersigned, give an undertaking to the following effect with regard to our article entitled
“_______________________________________________________________________________________________________________________________________________________________________________
________________________________________________________________________________” submitted for publication in (Journal title)________________________________________________ _______________________________________________________Vol.________, Year _________:-
1. The article mentioned above has not been published or submitted to or accepted for publication in any form, in any other journal.
2. We also vouchsafe that the authorship of this article will not be contested by anyone whose name(s) is/are not listed by us here.
3. I/We declare that I/We contributed significantly towards the research study i.e., (a) conception, design and/or analysis and interpretation of data and to (b) drafting the article or revising it critically for important intellectual content and on (c) final approval of the version to be published.
4. I/We hereby acknowledge ADRs conflict of interest policy requirement to scrupulously avoid direct and indirect conflicts of interest and, accordingly, hereby agree to promptly inform the editor or editor's designee of any business, commercial, or other proprietary support, relationships, or interests that I/We may have which relate directly or indirectly to the subject of the work.
5. I/We also agree to the authorship of the article in the following sequence:-
Authors' Names (in sequence) Signature of Authors
1. _____________________________________ _____________________________________
2. _____________________________________ _____________________________________
3. _____________________________________ _____________________________________
4. _____________________________________ _____________________________________
5. _____________________________________ _____________________________________
6. _____________________________________ _____________________________________
7. _____________________________________ _____________________________________
8. _____________________________________ _____________________________________
Important
(I). All the authors are required to sign independently in this form in the sequence given above. In case an author has left the institution/ country and whose whereabouts are not known, the senior author may sign on his/ her behalf taking the responsibility.
(ii). No addition/ deletion/ or any change in the sequence of the authorship will be permissible at a later stage, without valid reasons and permission of the Editor.
(iii). If the authorship is contested at any stage, the article will be either returned or will not be
processed for publication till the issue is solved.